FrancophonIA/ELRC3.0 huggingface dataset:
English: Psychiatric disorders confusional state anxiety, auditory hallucination, insomnia, agitation, disorientation, hallucination, visual hallucination, depression, paranoia, irritability, depression aggravated, nervousness, affect lability, mental status changes, anxiety aggravated, confusion aggravated delirium, psychotic disorder, suicidal ideation, suicide attempt, thought blocking, abnormal dreams, aggressiveness
Croatian: Psihijatrijski poremećaji stanje smetenosti anksioznost, slušne halucinacije, nesanica, agitacija, dezorijentacija, halucinacije, vidne halucinacije, depresija, paranoja, razdražljivost, pogoršanje depresije, nervoza, afektivna labilnost, promjene mentalnog statusa, pogoršanje anksioznosti, pogoršanje smetenosti delirij, psihotični poremećaj, suicidalna ideacija, pokušaj suicida, blokada misli, neuobičajeni snovi, agresivnost
English: Range aResponders were defined as those patients who 1) experienced a ≥ 30% drop in VASPI score compared to baseline; 2) had stable or decreased concomitant opioid analgesics; and 3) had opiate type unchanged from preinfusion if receiving opiates.
Croatian: Raspon aBolesnici s odgovorom definirani su kao bolesnici koji su: 1) imali pad ≥ 30% u rezultatu VASPI u usporedbi s onim prije liječenja; 2) primali su stabilnu ili smanjenu dozu opioidnih analgetika; i 3) vrsta opioida im nije promijenjena ako su ih primali prije infuzije. b164 bolesnika dalo je rezultate VASPI za zikonotid na kraju titracije SD - standardna devijacija
English: LIST OF EXCIPIENTS methionine, sodium chloride, water for injections, hydrochloric acid and sodium hydroxide.
Croatian: POPIS POMOĆNIH TVARI metionin, natrijev klorid, voda za injekcije, kloridna kiselina i natrijev hidroksid
English: In rat fertility studies, there were no effects in males while reductions in corpora lutea; implantation sites and number of live embryos were observed in females.
Croatian: U ispitivanjima plodnosti na štakorima nije bilo učinaka u mužjaka dok su u ženki opažena smanjenja žutog tijela, mjesta implantacije i broja živih embrija.
English: Mean VASPI score at end of initial titration in mm (SD) % improvement in VASPI score at end of initial titration (SD) Respondera n (%)
Croatian: VASPI na kraju početne titracije u mm (SD) % poboljšanja u rezultatu VASPI na kraju početne titracije (SD)
English: B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2.)
Croatian: Lijek se izdaje na ograničeni recept (vidjeti Dodatak I: Sažetak opisa svojstava lijeka, dio 4.2.)
English: The medicine will be administered continuously from a pump either implanted into your abdominal wall or placed externally in a belt pouch.
Croatian: Lijek će biti primijenjen kontinuirano iz pumpe koja je ili ugrađena
English: QUALITATIVE AND QUANTITATIVE COMPOSITION One ml solution contains 100 μg ziconotide (as acetate).
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Jedan ml otopine sadrži 100 μg zikonotida (u obliku zikonotidacetata).
English: Warnings and precautions Talk to your doctor before you are given Prialt - The effects of long-term treatment of Prialt are uncertain at this time and the possibility of toxic effects on the spinal cord have not yet been ruled out.
Croatian: - Ovog se trenutka ne zna pouzdano koji su učinci dugotrajnog liječenja Prialtom pa mogućnost toksičnih učinaka na kralježničnu moždinu još nije isključena.
English: Decreased appetite, anxiety or worsened anxiety, hallucinations, inability to fall or stay asleep, agitation, disorientation, depression or worsened depression, nervousness, mood swings, mental status changes (thinking abnormal, confusion), paranoia, irritability, worsened confusion, difficulty with learning, memory or thinking, reflexes absent or impaired, problems expressing or understanding words, slurred speech, difficulty with speech or loss of ability to speak, sluggishness, balance or coordination impaired, burning sensation, increased abnormal sensation, reduced level of consciousness (unresponsive or almost unconscious), sedation, difficulty in concentrating, problems with the sense of smell, odd or no sense of taste, shaking, pins and needles, double vision, visual disturbance, intolerance to light, tinnitus (ringing in the ears), dizziness or spinning sensation, lightheadedness or dizziness when standing, low blood pressure, shortness of breath, dry mouth, abdominal pain, worsened nausea, diarrhoea, constipation, sweating, itching, muscle weakness, muscle spasms, muscle cramp, muscle or joint pain, difficult or painful urination, difficulty starting or controlling urination, feeling jittery, falling, pain or pain exacerbated, fatigue, feeling cold, swelling of the face, legs or feet, chest pain, blood chemistry changes, mental impairment and weight decreased.
Croatian: Često (mogu se javiti u 1 do 10 korisnika na 100) Smanjeni apetit, tjeskoba ili pogoršana tjeskoba, halucinacije, nemogućnost usnivanja ili održavanja sna, uznemirenost, gubitak orijentacije, depresija ili pogoršana depresija, nervoza, promjene raspoloženja, promjene mentalnog statusa (poremećeno mišljenje, smetenost), paranoja, razdražljivost, pogoršana smetenost, otežano učenje, pamćenje ili razmišljanje, odsutni ili oštećeni refleksi, teškoće s izražavanjem ili razumijevanjem riječi, nerazumljiv govor, teškoće s govorom ili gubitak sposobnosti govora, tromost, oštećena ravnoteža ili koordinacija, osjećaj žarenja, povećan poremećaj osjeta, snižena razina svijesti (bez odgovora ili gotovo bez svijesti), sedacija, teškoće s koncentracijom, teškoće s osjetom okusa, čudan okus ili bez osjeta okusa, drhtanje, trnci i bockanje, dvoslike, smetnje vida, nepodnošenje svjetla, tinitus (zvonjava u ušima), omaglica ili osjećaj vrtnje, ošamućenost ili omaglica u stojećem položaju, nizak krvni tlak, nedostatak zraka, suha usta, bol u trbuhu, pogoršana mučnina, proljev, zatvor, znojenje, svrbež, mišićna slabost, spazam mišića, grčevi u mišićima, bol u mišićima ili zglobovima, otežano ili bolno mokrenje, teškoće sa započinjanjem ili kontrolom mokrenja, osjećaj nervoze, padanje, bol ili pojačana bol, umor, osjećaj hladnoće, oticanje lica, nogu ili stopala, bol u prsnom košu, biokemijske promjene krvi, mentalno oštećenje i smanjena težina.
English: 1 vial of 5 ml 5ml
Croatian: 1 bočica od 5 ml 5 ml
English: 100 micrograms /1ml
Croatian: 100 mikrograma/1 ml
English: 1 vial of 20 ml
Croatian: 1 bočica od 20 ml
English: Strict aseptic procedures must be used during the preparation and handling of the solution for infusion and refilling of the pump.
Croatian: Prilikom pripreme i rukovanja otopinom za infuziju i ponovnog punjenja pumpe, potrebno se strogo pridržavati aseptičkog postupka.
English: EU/1/04/302/002 - 2 ml solution for infusion.
Croatian: EU/1/04/302/002 - 2 ml otopina za infuziju
English: Nervous system disorders dizziness, nystagmus, memory impairment, headache, somnolence dysarthria, amnesia, dysgeusia, tremor, balance impaired, ataxia, aphasia, burning sensation, sedation, paraesthesia, hypoaesthesia, disturbance in attenti on, speech disorder, areflexia, coordination abnorm al, dizziness postural, cognitive disorder, hyperaesthesia, hyporeflexia, ageusia, depressed level of consciousness, dysaesthesia, parosmia, mental impairment incoherence, loss of consciousness, coma, stupor, convulsions, cerebrovascular accident, encephalopathy
Croatian: Poremećaji živčanog sustava omaglica, nistagmus, slabljenje pamćenja, glavobolja, somnolencija dizartrija, amnezija, disgeuzija, tremor, poremećaj ravnoteže, ataksija, afazija, osjećaj žarenja, sedacija, parestezija, hipoestezija, smetnje pozornosti, poremećaj govora, arefleksija, poremećena koordinacija, posturalna omaglica, kognitivni poremećaj, hiperestezija, hiporefleksija, ageuzija, snižena razina svijesti, disestezija, parosmija, mentalno oštećenje inkoherencija, gubitak svijesti, koma, stupor, konvulzije, cerebrovaskularni događaj, encefalopatija
English: 200 micrograms/2ml
Croatian: 200 mikrograma/2 ml
English: MARKETING AUTHORISATION NUMBER(S) EU/1/04/302/004 - 20 ml solution for infusion
Croatian: BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/04/302/004 - 20 ml otopina za infuziju
English: Marketing Authorisation Holder RIEMSER Pharma GmbH An der Wiek 7
Croatian: Nositelj odobrenja za stavljanje lijeka u promet RIEMSER Pharma GmbH An der Wiek 7
English: 1 vial of 2 ml 2ml
Croatian: 1 bočica od 2 ml 2 ml
English: MARKETING AUTHORISATION NUMBER(S) EU/1/04/302/004
Croatian: 12. BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/04/302/004
English: Alternative dosing regimens including initiation of dosing with lower doses of ziconotide and bolus administration have been explored in a limited number of studies available in the literature.
Croatian: U ograničenom broju ispitivanja dostupnih u literaturi, istraživani su drugi mogući režimi doziranja uključujući početak doziranja primjenom nižih doza zikonotida i bolusa.
English: Package leaflet: Information for the patient Prialt 100 micrograms/ml solution for infusion Ziconotide
Croatian: Uputa o lijeku: Informacija za bolesnika Prialt 100 mikrograma/ml otopina za infuziju zikonotid
English: Do not use this medicine if you notice any discolouration or cloudiness or if particulate matter is observed.
Croatian: Ovaj lijek se ne smije upotrijebiti ako primijetite da je promijenio boju ili je mutan ili su u njemu opažene čestice.
English: 500 micrograms/5ml
Croatian: 500 mikrograma/5 ml
English: 1 vial of 1 ml 1ml
Croatian: 1 bočica od 1 ml 1 ml
English: MARKETING AUTHORISATION NUMBER(S) EU/1/04/302/001 - 1 ml solution for infusion.
Croatian: BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/04/302/001 - 1 ml otopina za infuziju
English: Renal and urinary disorders urinary retention, urinary hesitation, dysuria, urinary incontinence acute renal failure
Croatian: Poremećaji bubrega i mokraćnog sustava retencija urina, otežani početak mokrenja, dizurija, urinarna inkontinencija akutno zatajenje bubrega
English: Musculoskeletal and connective tissue disorders pain in limb, myalgia, muscle spasms, muscle cramp, muscle weakness, arthralgia, peripheral swelling rhabdomyolysis, myositis, back pain, muscle twitching, neck pain
Croatian: Poremećaji mišićnokoštanog sustava i vezivnog tkiva bol u udovima, mialgija, mišićni spazam, mišićni grč, mišićna slabost, artralgija, periferno oticanje rabdomioliza, miozitis, bol u leđima, trzanje mišića, bol u vratu
English: Package leaflet: Information for the patient Prialt 25 micrograms/ml solution for infusion Ziconotide
Croatian: Uputa o lijeku: Informacija za bolesnika Prialt 25 mikrograma/ml otopina za infuziju zikonotid
English: Unless otherwise noted shows the incidence rates of adverse reactions reported in the intrathecal clinical trials with ziconotide (short- and long-term exposure).
Croatian: Stope incidencije nuspojava prijavljenih u kliničkim ispitivanjima intratekalne primjene zikonotida (kratkotrajna i dugotrajna izloženost) navedene su u tablici, osim kad je naznačeno drugačije.
English: If dilution is required, Prialt must be diluted aseptically with preservative-free sodium chloride 9 mg/ml (0.9%) solution for injection before use.
Croatian: Ako je potrebno razrjeđivanje, Prialt se mora prije primjene razrijediti u aseptičkim uvjetima s 0,9%-tnom (9 mg/ml) otopinom natrijeva klorida za injekcije bez konzervansa.
English: Pumps previously used to deliver other medicinal products must be washed out three times with sodium chloride 9 mg/ml (0.9%) solution for injection (preservative-free) before being filled with Prialt.
Croatian: Pumpe koje su već bile upotrijebljene za primjenu drugih lijekova, prije punjenja lijekom Prialt moraju se isprati tri puta 0,9%-tnom (9 mg/ml) otopinom natrijeva klorida za injekcije (bez konzervansa).
English: Pumps previously used to deliver other medicinal products must be washed out three times with sodium chloride 9 mg/ml (0.9%) solution for injection (preservative-free) before being filled with ziconotide.
Croatian: Pumpe koje su već bile upotrijebljene za primjenu drugih lijekova, prije punjenja zikonotidom moraju se isprati tri puta 0,9%-tnom (9 mg/ml) otopinom natrijeva klorida za injekcije (bez konzervansa).
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Prialt 100 μg/ml infusion
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Prialt 100 μg/ml infuzija zikonotid
English: Prialt should be inspected visually for particulate matter and discolouration prior to administration.
Croatian: Prije primjene Prialt treba vizualno pregledati zbog moguće prisutnosti čestica i promjene boje.
English: General disorders and administration site conditions gait abnormal, asthenia fatigue, pyrexia, lethargy, oedema peripheral, rigors, fall, chest pain, feeling cold, pain, feeling jittery, pain exacerbated difficulty in walking
Croatian: Opći poremećaji i reakcije na mjestu primjene poremećaj hoda, astenija umor, pireksija, letargija, periferni edem, tresavica, pad, bol u prsištu, osjećaj hladnoće, bol, osjećaj nervoze, pogoršanje bola teškoće pri hodu
English: Prialt was stable for 60 days at 37°C in the Synchromed pump previously exposed to the medicinal product.
Croatian: U pumpi Synchromed koja je prethodno bila izložena lijeku, Prialt je bio stabilan 60 dana pri temperaturi od 37°C.
English: The solution should not be used if discoloured or cloudy or if particulate matter is observed.
Croatian: Otopina se ne smije upotrijebiti ako je promijenila boju ili je mutna ili se u njoj opažaju čestice.
English: Each 2 ml vial contains 200 μg ziconotide (as acetate).
Croatian: Jedna bočica od 2 ml sadrži 200 μg zikonotida (u obliku zikonotidacetata).
English: CE marked pumps equivalent to the Synchromed and CADD-Micro pump should be used to deliver ziconotide.
Croatian: Za primjenu zikonotida treba upotrijebiti pumpe obilježene oznakom CE, ekvivalentne pumpama Synchromed i CADD-Micro.
English: Immune system disorders
Croatian: Poremećaji imunološkog sustava anafilaktička reakcijaa
English: Infection of the blood stream, delirium (feeling of mental confusion), psychotic disorder (abnormal thinking and perceptions), thought disorders, abnormal dreams, incoherence (inability to make sense), loss of consciousness, stupor (unresponsive/difficult to arouse), stroke, encephalopathy (brain disorder), aggressiveness, abnormal heart rhythm, difficulty breathing, indigestion, rash, muscle inflammation, back pain, muscle twitching, neck pain, acute kidney failure, abnormal heart trace measurements (ECG), raised body temperature, difficulty walking.
Croatian: Manje često (mogu se javiti u 1 do 10 korisnika na 1000) Infekcija krvnog optoka, delirij (osjećaj mentalne smetenosti), psihotični poremećaj (poremećeno mišljenje i percepcija), poremećaji misli, neuobičajeni snovi, inkoherencija (nesposobnost smislenog izražavanja), gubitak svijesti, stupor (bez reakcije/otežana budnost), moždani udar, encefalopatija (poremećaj mozga), agresivnost, poremećeni srčani ritam, otežano disanje, loša probava, osip, upala mišića, bol u leđima, trzanje mišića, bol u vratu, akutno zatajenje bubrega, poremećen zapis rada srca (EKG), povišena tjelesna temperatura, poteškoće s hodanjem.
English: NAME OF THE MEDICINAL PRODUCT Prialt 25 μg/ml solution for infusion ziconotide
Croatian: NAZIV LIJEKA Prialt 25 μg/ml otopina za infuziju zikonotid
English: Initial treatment assignment
Croatian: Podjela u početnom liječenju
English: - One ml solution contains 25 micrograms ziconotide (as acetate).
Croatian: - Jedan ml otopine sadrži 25 mikrograma zikonotida (u obliku zikonotidacetata).
English: Examination of the patency of the intrathecal catheter should be considered if the required ziconotide dose continually increases and there is no benefit or increase in adverse reactions.
Croatian: Ako se potrebna doza zikonotida neprekidno povećava, a nema poboljšanja ili povećanja nuspojava, treba provjeriti prohodnost intratekalnog katetera.
English: NAME OF THE MEDICINAL PRODUCT Prialt 100 micrograms/ml solution for infusion
Croatian: NAZIV LIJEKA Prialt 100 mikrograma/ml otopina za infuziju
English: Each 5 ml vial contains 500 μg ziconotide (as acetate).
Croatian: Jedna bočica od 5 ml sadrži 500 μg zikonotida (u obliku zikonotidacetata).
English: You may feel drowsy if you are given Prialt with certain other medicines used to treat pain.
Croatian: Ako ste primili Prialt s nekim drugim lijekovima protiv bolova, možda ćete osjećati pospanost.
English: NAME OF THE MEDICINAL PRODUCT Prialt 25 micrograms/ml solution for infusion
Croatian: NAZIV LIJEKA Prialt 25 mikrograma/ml otopina za infuziju
English: - Each 20 ml vial contains 500 micrograms ziconotide (as acetate).
Croatian: - Jedna bočica od 20 ml sadrži 500 mikrograma zikonotida (u obliku zikonotidacetata).
English: Very low circulating plasma concentrations of ziconotide may be observed following IT administration due to both the low IT infusion rate and relatively rapid plasma clearance.
Croatian: Zbog male brzine intratekalne infuzije i relativno brzog klirensa plazme, nakon intratekalne primjene mogu se opaziti vrlo niske cirkulirajuće koncentracije zikonotida u plazmi.
English: - The other ingredients (excipients) are methionine, sodium chloride, water for injections,
Croatian: - Ostali su sastojci (pomoćne tvari) metionin, natrijev klorid, voda za injekcije, kloridna kiselina i natrijev hidroksid.
English: Patients have experienced depressed levels of consciousness while receiving ziconotide.
Croatian: Tijekom primjene zikonotida bolesnici su pokazivali snižene razine svijesti.
English: Each ml contains 100 micrograms ziconotide (as acetate).
Croatian: Jedan ml sadrži 100 mikrograma zikonotida (u obliku zikonotidacetata).
English: It should be inspected visually for particulate matter and discolouration prior to administration.
Croatian: Prije primjene treba je vizualno pregledati zbog mogućih čestica i promjene boje.
English: Each 20 ml vial contains 500 μg ziconotide (as acetate).
Croatian: Jedna bočica od 20 ml sadrži 500 μg zikonotida (u obliku zikonotidacetata).
English: CE marked pumps equivalent to the Synchromed and CADD-Micro pump should be used to deliver Prialt.
Croatian: Za primjenu Prialta treba upotrijebiti pumpe obilježene oznakom CE, ekvivalentne pumpama Synchromed i CADD-Micro.
English: - One ml solution contains 100 micrograms ziconotide (as acetate).
Croatian: - Jedan ml otopine sadrži 100 mikrograma zikonotida (u obliku zikonotidacetata).
English: Each 1 ml vial contains 100 μg ziconotide (as acetate).
Croatian: Jedna bočica od 1 ml sadrži 100 μg zikonotida (u obliku zikonotidacetata).
English: Each vial contains 200 micrograms ziconotide (as acetate).
Croatian: Jedna bočica sadrži 200 mikrograma zikonotida (u obliku zikonotidacetata).
English: NAME OF THE MEDICINAL PRODUCT Prialt 100 micrograms/ml solution for infusion ziconotide
Croatian: Prialt 100 mikrograma/ml otopina za infuziju zikonotid
English: NAME OF THE MEDICINAL PRODUCT Prialt 25 micrograms/ml solution for infusion ziconotide
Croatian: Prialt 25 mikrograma/ml otopina za infuziju zikonotid
English: Mean VASPI score at baseline in mm (SD)
Croatian: Srednja vrijednost rezultata VASPI prije liječenja u mm (SD)
English: Caution should be exercised when ziconotide is administered to patients with impaired hepatic function.
Croatian: U bolesnika s oštećenom funkcijom jetre zikonotid treba primjenjivati s oprezom.
English: Each vial contains 100 micrograms ziconotide (as acetate).
Croatian: Jedna bočica sadrži 100 mikrograma zikonotida (u obliku zikonotidacetata).
English: _ _1 Neisseria meningitidis serogroup A polysaccharide* 5 micrograms Neisseria meningitidis serogroup C polysaccharide* 5 micrograms Neisseria meningitidis serogroup W-135 polysaccharide* 5 micrograms Neisseria meningitidis serogroup Y polysaccharide* 5 micrograms *conjugated to tetanus toxoid carrier protein 44 micrograms
Croatian: _ _1polisaharid Neisseria meningitidis grupe A* 5 mikrograma polisaharid Neisseria meningitidis grupe C* 5 mikrograma polisaharid Neisseria meningitidis grupe W -135*5 mikrograma polisaharid Neisseria meningitidis grupe Y* 5 mikrograma *konjugirano na tetanusni toksoid proteinski nosač 44 mikrograma
English: 10 vials + 10 pre-filled syringes + 20 needles
Croatian: 10 bočica+ 10 napunjenih štrcaljki + 20 igala
English: 10 vials + 10 pre-filled syringes
Croatian: 10 bočica+ 10 napunjenih štrcaljki
English: 1 vial + 1 prefilled syringe + 2 needles
Croatian: 1 bočica+ 1 napunjena štrcaljka + 2 igle
English: Route of Administration
Croatian: Put primjene Pakovanje Sastav
English: 1 vial + 1 prefilled syringe
Croatian: 1 bočica+ 1 napunjena štrcaljka
English: Strength Pharmaceutical Form
Croatian: Farmaceutski oblik Put primjene Unutarnje pakiranje Veličina pakiranja
English: 90 (3 x 30) tablets (multipack)
Croatian: 90 (3 x 30) tableta (kolektivna paket)
English: All these signs resolve spontaneously within 24 hours.
Croatian: Svi ti znakovi spontano nestaju u roku od 24 sata.
English: Contact with the applicator should be avoided.
Croatian: Treba izbjegavati dodir s aplikatorom.
English: Consequently, it is recommended that recently treated animals do not sleep with owners, especially children.
Croatian: Preporučuje se da nedavno tretirane životinje ne spavaju s vlasnicima, osobito s djecom.
English: This means that they kill parasites that live inside the body of animals.
Croatian: To znači da uništavaju parazite koji žive u tijelu životinja.
English: Handling of treated animals should be limited until the application site is dry and children should not play with treated animals during this period.
Croatian: Treba ograničiti rukovanje s tretiranim životinjama dok se mjesto primjene ne osuši, a djeci se ne smije dopustiti da se igraju s tretiranim životinjama tijekom tog razdoblja.
English: This summary was last updated in July 2019.
Croatian: Pregled informacija posljednji je put ažuriran u 7. 2019.
English: Further information on Broadline can be found on the Agency's website: ema.europa.eu/medicines/veterinary/EPAR/broadline.
Croatian: Više informacija o MP-u Broadline dostupno je na internetskim stranicama Agencije:ema.europa.eu/medicines/veterinary/EPAR/broadline.
English: What is Broadline and what is it used for?
Croatian: Što je Broadline i za što se koristi?
English: Other information about Broadline
Croatian: Ostale informacije o VMP-u Broadline
English: Fipronil kills adult parasites.
Croatian: Fipronilom se uništavaju odrasli paraziti.
English: It treats tick infestations and prevents new infestations for up to three weeks.
Croatian: Njime se tretiraju infestacije krpeljima i sprječavaju nove infestacije u razdoblju do tri tjedna.
English: People applying the medicine should not smoke, eat or drink while doing so and should wash their hands after handling the product.
Croatian: Osobe koje primjenjuju ovaj VMP ne smiju pušiti, jesti niti piti prilikom primjene, a nakon rukovanja njime trebaju oprati ruke.
English: If the cat licks the application site, temporary excessive salivation may occur.
Croatian: Ako mačka liže mjesto primjene, može se pojaviti prolazno prekomjerno slinjenje.
English: Broadline received a marketing authorisation valid throughout the EU on 4 December 2013.
Croatian: VMP Broadline dobio je odobrenje za stavljanje u promet koje je na snazi u EU-u od 4. prosinca 2013.
English: The content of one full applicator (appropriate to the cat's weight) is applied directly to the cat's skin after parting the hair, in a single spot on the middle of the neck.
Croatian: Sadržaj punog aplikatora (primjerenog težini mačke) nanosi se izravno na kožu mačke na jednom mjestu na sredini vrata nakon što se razmakne dlaka.
English: Broadline must not be used in sick or recovering animals.
Croatian: Broadline se ne smije primjenjivati u bolesnih životinja ili onih koje se oporavljaju.
English: For lungworm a second treatment may be recommended one month after the initial treatment.
Croatian: U slučaju plućnih oblića, mjesec dana nakon prvog tretmana može se preporučiti drugi tretman.
English: This means that they kill external parasites that live on the skin or in the fur of animals, such as fleas and ticks.
Croatian: To znači da uništavaju vanjske parazite koji žive na koži ili u krznu životinja, poput buha i krpelja.